AskBorsa

New Medical Centre Alexandria

AMES
Fiscal year starts in January · currency EGP · latest: Q2 2026
Next results: Q3 2026 — expected around 15 November 2026published last year on 13 November 2025Results calendar ←
33.74EGP+3.82% today1w +3.9%1m −33.0%delayed · 3 November
Net profit · 2024
29.82million
▲ 402.6% vs 2023
Total assets · 2024
366million
▲ 22.4% vs 2023
Shareholders' equity · 2024
221million
▲ 15.6% vs 2023
Operating cash flow · 2024
26.51million
▲ 788.2% vs 2023

Key facts

Source: annual statements 2024
  • New Medical Centre Alexandria's net profit in 2024 was 29.82 million EGP, up 402.6% from 5.93 million EGP in 2023.
  • Total assets at the end of 2024 were 366 million EGP, and shareholders' equity 221 million EGP.
  • Operating cash flow in 2024 was positive at 26.51 million EGP.

New Medical Centre Alexandria's Q3 2026 results are expected around 15 November — we email you the day they land

One email on the day, no account, and a one-click stop in the email itself.

orFollow on TelegramEvery result as it lands, in the @askborsa channel

By subscribing you agree to receive these alerts only. Privacy policy

AI summary

Preparing a summary of the latest results…

Annual net profit last 5 years
Net profit
20.85million
26.45million
7.45million
5.93million
29.82million
20202021202220232024

Summarised financial statements

Excel · Pro
Swipe the table to see the other years.
Item · EGP20202021202220232024
Income statement
Net profit20.85 million26.45 million7.45 million5.93 million29.82 million
Gross profit87.92 million117 million88.77 million77.9 million120 million
Total assets318 million352 million314 million299 million366 million
Total liabilities92.41 million102 million80.58 million108 million145 million
Shareholders' equity225 million250 million233 million191 million221 million
Total liabilities and equity318 million352 million314 million299 million366 million
Operating cash flow22.06 million55.6 million-2.39 million-3.85 million26.51 million
Investing cash flow3.27 million-13.75 million-2.92 million-9.61 million-40.51 million
Financing cash flow-34.58 million-18.61 million25.16 million—6.14 million
Net change in cash7.8 million23.24 million19.85 million-13.47 million-7.86 million
Sign up free to see the full five years for every period.
Sign up free in seconds
With Google or your email, no password.

Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. What does this line mean?

Results by period

One page per period: the figures against the same period a year earlier, and the official report.

Financial reports (6)

Other companies in Health Care & Pharmaceuticals

Ranked by latest annual net profit
All companies in the sector ←